CORCEPT THERAPEUTICS INC Loss Contingency, Receivable, Current
CORCEPT THERAPEUTICS INC (CORT) had Loss Contingency, Receivable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyReceivableCurrent · last filed 2025-02-26
- 2024-12-31: Loss Contingency, Receivable, Current $0.00.
- 2024-09-30: Loss Contingency, Receivable, Current $0.00.
- 2024-06-30: Loss Contingency, Receivable, Current $0.00.
- 2024-03-31: Loss Contingency, Receivable, Current $0.00.
| Period end | Loss Contingency, Receivable, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-29 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-01 |
| 2023-12-31 | $14.00M 10-K · filed 2025-02-26 |
| 2023-09-30 | $14.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $14.00M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $14.00M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $14.00M 10-K · filed 2024-02-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |